Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

MLS128 antibody-induced suppression of colon cancer cell growth is mediated by a desmocollin and a 110 kDa glycoprotein.

Shuck SC, Hong T, Kalkum M, Igarashi R, Kajiya K, Termini J, Yamamoto K, Fujita-Yamaguchi Y.

Biosci Trends. 2019 Jul 22;13(3):216-224. doi: 10.5582/bst.2019.01074. Epub 2019 Jun 5.

2.

Mass spectrometric revival of an l-rhamnose- and d-galactose-specific lectin from a lost strain of Streptomyces.

Fujita-Yamaguchi Y, Bagramyan K, Yamaguchi Y, Ikeda A, Dohmae N, Hong TB, Kalkum M.

J Biol Chem. 2018 Jan 5;293(1):368-378. doi: 10.1074/jbc.M117.812719. Epub 2017 Nov 3.

3.

An aqueous extract from toad skin prevents gelatinase activities derived from fetal serum albumin and serum-free culture medium of human breast carcinoma MDA-MB-231 cells.

Nakata M, Kawaguchi S, Oikawa A, Inamura A, Nomoto S, Miyai H, Nonaka T, Ichimi S, Fujita-Yamaguchi Y, Luo C, Gao B, Tang W.

Drug Discov Ther. 2015 Dec;9(6):417-21. doi: 10.5582/ddt.2015.01060.

4.

Knockdown of AT-rich interaction domain (ARID) 5B gene expression induced AMPKα2 activation in cardiac myocytes.

Hirose-Yotsuya L, Okamoto F, Yamakawa T, Whitson RH, Fujita-Yamaguchi Y, Itakura K.

Biosci Trends. 2015 Dec;9(6):377-85. doi: 10.5582/bst.2015.01159.

5.

Affinity Chromatography of Native and Recombinant Proteins from Receptors for Insulin and IGF-I to Recombinant Single Chain Antibodies.

Fujita-Yamaguchi Y.

Front Endocrinol (Lausanne). 2015 Oct 27;6:166. doi: 10.3389/fendo.2015.00166. eCollection 2015. Review.

6.

Toad skin extract cinobufatini inhibits migration of human breast carcinoma MDA-MB-231 cells into a model stromal tissue.

Nakata M, Mori S, Kamoshida Y, Kawaguchi S, Fujita-Yamaguchi Y, Gao B, Tang W.

Biosci Trends. 2015 Aug;9(4):266-9. doi: 10.5582/bst.2015.01109.

7.

Susceptibility to proteases of anti-Tn-antigen MLS128 binding glycoproteins expressed in human colon cancer cells.

Oura F, Yajima Y, Nakata M, Taniue K, Akiyama T, Nakada H, Yamamoto K, Fujita-Yamaguchi Y.

Biosci Trends. 2015 Feb;9(1):49-55. doi: 10.5582/bst.2014.01127.

8.

Migration of breast cancer cells into reconstituted type I collagen gels assessed via a combination of frozen sectioning and azan staining.

Fukuda K, Kamoshida Y, Kurokawa T, Yoshida M, Fujita-Yamaguchi Y, Nakata M.

Biosci Trends. 2014 Aug;8(4):212-6.

9.
10.

Characterization of anti-Tn-antigen MLS128 binding proteins involved in inhibiting the growth of human colorectal cancer cells.

Zamri N, Masuda N, Oura F, Kabayama K, Yajima Y, Nakada H, Yamamoto K, Fujita-Yamaguchi Y.

Biosci Trends. 2013 Oct;7(5):221-9.

11.

Expression and structural characterization of anti-T-antigen single-chain antibodies (scFvs) and analysis of their binding to T-antigen by surface plasmon resonance and NMR spectroscopy.

Yuasa N, Koyama T, Subedi GP, Yamaguchi Y, Matsushita M, Fujita-Yamaguchi Y.

J Biochem. 2013 Dec;154(6):521-9. doi: 10.1093/jb/mvt089. Epub 2013 Oct 4.

PMID:
24098012
12.

Renewed interest in basic and applied research involving monoclonal antibodies against an oncofetal Tn-antigen.

Fujita-Yamaguchi Y.

J Biochem. 2013 Aug;154(2):103-5. doi: 10.1093/jb/mvt052. Epub 2013 Jun 4. Review.

PMID:
23740330
13.
14.

Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.

Yuasa N, Ogawa H, Koizumi T, Tsukamoto K, Matsumoto-Takasaki A, Asanuma H, Nakada H, Fujita-Yamaguchi Y.

J Biochem. 2012 Apr;151(4):371-81. doi: 10.1093/jb/mvs007. Epub 2012 Feb 8.

PMID:
22318767
15.
16.

Overproduction of anti-Tn antibody MLS128 single-chain Fv fragment in Escherichia coli cytoplasm using a novel pCold-PDI vector.

Subedi GP, Satoh T, Hanashima S, Ikeda A, Nakada H, Sato R, Mizuno M, Yuasa N, Fujita-Yamaguchi Y, Yamaguchi Y.

Protein Expr Purif. 2012 Mar;82(1):197-204. doi: 10.1016/j.pep.2011.12.010. Epub 2012 Jan 8.

PMID:
22245752
17.

Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.

Matsumoto-Takasaki A, Hanashima S, Aoki A, Yuasa N, Ogawa H, Sato R, Kawakami H, Mizuno M, Nakada H, Yamaguchi Y, Fujita-Yamaguchi Y.

J Biochem. 2012 Mar;151(3):273-82. doi: 10.1093/jb/mvr138. Epub 2011 Dec 8.

PMID:
22161472
18.
19.

Characterization of three different single chain antibodies recognizing non-reducing terminal mannose residues expressed in Escherichia coli by an inducible T7 expression system.

Matsumoto-Takasaki A, Yuasa N, Katagiri D, Koyama T, Sakai K, Zamri N, Phung S, Chen S, Nakada H, Nakata M, Fujita-Yamaguchi Y.

J Biochem. 2011 Oct;150(4):439-50. doi: 10.1093/jb/mvr078. Epub 2011 Jun 21.

PMID:
21693545
20.

Invasion of carcinoma cells into reconstituted type I collagen gels: visual real-time analysis by time-lapse microscopy.

Sakai K, Kurokawa T, Furui Y, Kuronuma Y, Sekiguchi M, Ando J, Inagaki Y, Tang W, Nakata M, Fujita-Yamaguchi Y.

Biosci Trends. 2011;5(1):10-6.

21.

Preparation of asialo-agalacto-glycophorin A for screening of anti-Tn antibodies.

Koizumi T, Matsumoto-Takasaki A, Nakada H, Nakata M, Fujita-Yamaguchi Y.

Biosci Trends. 2010 Dec;4(6):308-11.

22.

Production of anti-carbohydrate antibodies by phage display technologies: potential impairment of cell growth as a result of endogenous expression.

Yuasa N, Zhang W, Goto T, Sakaue H, Matsumoto-Takasaki A, Kimura M, Ohshima H, Tsuchida Y, Koizumi T, Sakai K, Kojima T, Yamamoto K, Nakata M, Fujita-Yamaguchi Y.

J Biol Chem. 2010 Oct 1;285(40):30587-97. doi: 10.1074/jbc.M110.107284. Epub 2010 Jul 28.

23.

Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.

Sakai K, Yuasa N, Tsukamoto K, Takasaki-Matsumoto A, Yajima Y, Sato R, Kawakami H, Mizuno M, Takayanagi A, Shimizu N, Nakata M, Fujita-Yamaguchi Y.

J Biochem. 2010 Jun;147(6):809-17. doi: 10.1093/jb/mvq014. Epub 2010 Feb 10.

PMID:
20147453
24.

Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.

Morita N, Yajima Y, Asanuma H, Nakada H, Fujita-Yamaguchi Y.

Biosci Trends. 2009 Feb;3(1):32-7.

25.

Mechanisms of antibody-mediated insulin-like growth factor I receptor (IGF-IR) down-regulation in MCF-7 breast cancer cells.

Ohtani M, Numazaki M, Yajima Y, Fujita-Yamaguchi Y.

Biosci Trends. 2009 Aug;3(4):131-8.

26.

Isolation and characterization of anti-T-antigen single chain antibodies from a phage library.

Matsumoto-Takasaki A, Horie J, Sakai K, Furui Y, Sato R, Kawakami H, Toma K, Takayanagi A, Shimizu N, Fujita-Yamaguchi Y.

Biosci Trends. 2009 Jun;3(3):87-95.

27.

Production of a human antibody fragment against the insulin-like growth factor І receptor as a fusion protein.

Kusada Y, Morizono T, Sakai K, Takayanagi A, Shimizu N, Fujita-Yamaguchi Y.

Drug Discov Ther. 2008 Aug;2(4):245-53.

28.

Influenza PR8 HA-specific Fab fragments produced by phage display methods.

Asanuma H, Matsumoto-Takasaki A, Suzuki Y, Tamura S, Sata T, Kusada Y, Matsushita M, Fujita-Yamaguchi Y.

Biochem Biophys Res Commun. 2008 Feb 8;366(2):445-9. Epub 2007 Dec 5.

PMID:
18067856
29.

An overview of currently available anti-insulin-like growth factor I receptor antibodies.

Kusada Y, Fujita-Yamaguchi Y.

Biosci Trends. 2007 Dec;1(3):128-33. Review.

30.

Construction and characterization of single-chain antibodies against human insulin-like growth factor-I receptor from hybridomas producing 1H7 or 3B7 monoclonal antibody.

Kusada Y, Morizono T, Matsumoto-Takasaki A, Sakai K, Sato S, Asanuma H, Takayanagi A, Fujita-Yamaguchi Y.

J Biochem. 2008 Jan;143(1):9-19. Epub 2007 Oct 23.

PMID:
17956902
31.

Construction of a recombinant single chain antibody recognizing nonreducing terminal mannose residues applicable to immunohistochemistry.

Yuasa N, Iida N, Sakaue H, Zhang W, Wilczynski S, Fujita-Yamaguchi Y.

Biosci Trends. 2007 Oct;1(2):108-12.

32.

Long- and short-time immunological memory in different strains of mice given nasally an adjuvant-combined nasal influenza vaccine.

Asanuma H, Fujihashi K, Miyakoshi T, Yoshikawa T, Fujita-Yamaguchi Y, Kojima N, Nakata M, Suzuki Y, Tamura S, Kurata T, Sata T.

Vaccine. 2007 Sep 28;25(39-40):6975-80. Epub 2007 Jul 16.

PMID:
17716790
33.
34.

Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodies.

Sakai K, Shimizu Y, Chiba T, Matsumoto-Takasaki A, Kusada Y, Zhang W, Nakata M, Kojima N, Toma K, Takayanagi A, Shimizu N, Fujita-Yamaguchi Y.

Biochemistry. 2007 Jan 9;46(1):253-62.

PMID:
17198396
36.

Epidermal growth factor-mediated growth control of confluent mammary epithelial cells cultured on artificial basement membrane.

Guo Q, Tang W, Kokudo N, Sugawara Y, Miki K, Karako H, Qu X, Nakata M, Fujita-Yamaguchi Y, Makuuchi M.

Int J Mol Med. 2005 Sep;16(3):395-9.

PMID:
16077945
37.

Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo.

Ye JJ, Liang SJ, Guo N, Li SL, Wu AM, Giannini S, Sachdev D, Yee D, Brünner N, Ikle D, Fujita-Yamaguchi Y.

Horm Metab Res. 2003 Nov-Dec;35(11-12):836-42.

PMID:
14710366
38.

Systematic search for single nucleotide polymorphisms in the 5' flanking region of the human phosphodiesterase 3B gene: absence of evidence for major effects of identified polymorphisms on susceptibility to Japanese type 2 diabetes.

Osawa H, Niiya T, Onuma H, Murakami A, Ochi M, Nishimiya T, Ogura T, Kato K, Shimizu I, Fujii Y, Ohashi J, Yamada K, Liang SJ, Manganiello VC, Fujita-Yamaguchi Y, Makino H.

Mol Genet Metab. 2003 May;79(1):43-51.

PMID:
12765845
39.
40.

The role of insulin-like growth factor-II in cancer growth and progression evidenced by the use of ribozymes and prostate cancer progression models.

Guo N, Ye JJ, Liang SJ, Mineo R, Li SL, Giannini S, Plymate SR, Sikes RA, Fujita-Yamaguchi Y.

Growth Horm IGF Res. 2003 Feb;13(1):44-53.

PMID:
12550081
41.

IGFBPs modulate IGF-I- and high glucose-controlled growth of human retinal endothelial cells.

Giannini S, Cresci B, Pala L, Ciucci A, Franchini A, Manuelli C, Fujita-Yamaguchi Y, Cappugi P, Zonefrati R, Rotella CM.

J Endocrinol. 2001 Nov;171(2):273-84.

PMID:
11691647
42.

Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth.

Li SL, Liang SJ, Guo N, Wu AM, Fujita-Yamaguchi Y.

Cancer Immunol Immunother. 2000 Jul;49(4-5):243-52.

PMID:
10941907
43.
44.

Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon.

Mineo R, Fichera E, Liang SJ, Fujita-Yamaguchi Y.

Biochem Biophys Res Commun. 2000 Feb 24;268(3):886-92.

PMID:
10679300
45.

Cardiac type cGMP-inhibited phosphodiesterase (PDE3A) gene structure: similarity and difference to adipocyte type PDE3B gene.

Kasuya J, Liang SJ, Goko H, Park SH, Kato K, Xu ZD, Hockman S, Manganiello VC, Fujita-Yamaguchi Y.

Biochem Biophys Res Commun. 2000 Feb 24;268(3):827-34.

PMID:
10679291
46.

Human glomerular endothelial cells IGFBPs are regulated by IGF-I and TGF-beta1.

Giannini S, Cresci B, Pala L, Ciucci A, Manuelli C, Fujita-Yamaguchi Y, Cappugi P, Rotella CM.

Mol Cell Endocrinol. 1999 Aug 20;154(1-2):123-36.

PMID:
10509807
47.

Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.

Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, Siddle K, Goldfine ID, Belfiore A.

Clin Cancer Res. 1999 Jul;5(7):1935-44.

48.

Mechanisms of desensitization to a PDE inhibitor (milrinone) in conscious dogs with heart failure.

Sato N, Asai K, Okumura S, Takagi G, Shannon RP, Fujita-Yamaguchi Y, Ishikawa Y, Vatner SF, Vatner DE.

Am J Physiol. 1999 May;276(5):H1699-705. doi: 10.1152/ajpheart.1999.276.5.H1699.

PMID:
10330256
49.

Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II ribonucleic acid in vitro and in prostate cancer cells.

Xu ZD, Oey L, Mohan S, Kawachi MH, Lee NS, Rossi JJ, Fujita-Yamaguchi Y.

Endocrinology. 1999 May;140(5):2134-44.

PMID:
10218964

Supplemental Content

Loading ...
Support Center